We have identified the mouse exon VII splice variant of the Ets-1 transcription factor. The variant is expressed in all cell lines which express ets-1, at lower levels, it is also expressed in the mouse embryo in vivo. The corresponding protein, p42Ets-1, is a transcription factor as it is able to bind to specific DNA sequences and to transactivate a bona fide ETS reporter vector. A comparison of optimal DNA-binding sites shows that p42Ets-1 binds to more various DNA sequences than p51Ets-1; p42Ets-1 recognizes the same optimal consensus sequence as p51Ets-1, but also many variations of it, mainly at base À1, which is located just prior to the GGAA/T core sequence. The binding differences were quantified by surface plasmon resonance analyses and the protein region responsible for the differences in DNA sequence recognition located in the Val 280 -Glu 302 fragment, which is encoded by exon VII. The specific DNA-binding properties of each isoform translates into clear differences in activity, p42Ets-1 transactivates the natural VE-cadherin gene promoter through both ETS-binding site (EBS)2 and EBS4 whereas p51Ets-1 is mainly active on EBS4. Altogether, our data suggest that p42Ets-1 acts as a distinct transcription factor from p51Ets-1. Oncogene (2003) 22, 9156-9164.
Introduction
The ETS family is composed of several transcription factors which share a conserved sequence of 85 amino acids named the ETS domain. This domain folds into a winged helix-turn-helix motif composed of three a helices packed against a four-stranded, antiparallel b-sheet. Helix H3 contacts the DNA major groove Mo et al., 2000; Garvie et al., 2001) over the consensus DNA sequence GGAA/T (ETS-binding site (EBS), Ghysdael and Boureux, 1997) .
In the Ets-1 transcription factor (p51Ets-1), two inhibitory regions located on either side of the ETS domain associate together and regulate p51Ets-1 affinity for DNA: in the absence of DNA, the N-terminal part of this region, coded by exon VII, interacts with the ETS domain and with the C-terminal region to create an autoinhibited conformation. When p51Ets-1 is bound to DNA, the inhibitory a helix 1 (HI1) is unfolded and the inhibitory module unpacked, this status correlates with a higher affinity for DNA (Petersen et al., 1995; Jonsen et al., 1996; Garvie et al., 2002) . In p51Ets-1, the domain encoded by exon VII contains four serine residues that are phosphorylated upon Ca 2 þ activation (Rabault and Ghysdael, 1994) . This phosphorylation inhibits DNA binding by reinforcing the autoinhibition (Rabault and Ghysdael, 1994; Cowley and Graves, 2000) . Thus, the domain encoded by exon VII plays a central role in p51Ets-1 as it is directly involved in the regulation of DNA binding and is the target of second messenger pathways.
In human and rat, an Ets-1 variant that arises from the splicing of exon VII has been identified (p42Ets-1, Koizumi et al., 1990; Jorcyk et al., 1991; Bellacosa et al., 1994) . This variant displays specific properties that are not shared by the full-length protein; it misses the essential serine residues and is not subject to Ca 2 þ -dependent phosphorylation and inhibition of DNA binding (Fisher et al., 1994; Rabault and Ghysdael, 1994; Cowley and Graves, 2000) , moreover, p42Ets-1 induces colon cancer cell apoptosis (Huang et al., 1997) and overexpression of caspase-1/ICE in these cells while p51Ets-1 does not (Li et al., 1999) . The role of p42Ets-1 has not been extensively studied and several fundamental questions concerning its functions remain: is p42Ets-1 a transcription factor? if yes, does it regulate different target genes than p51Ets-1, such as caspase-1/ ICE, by a direct activation of specific EBS on their promoters or by an indirect mechanism?
During our studies on the role of Ets-1 in the regulation of the endothelial VE-cadherin (Lelie`vre et al., 2000) and fli-1 ( Lelie`vre et al., 2002 ) genes, we have repeatedly observed the expression of an ets-1-related transcript that we have identified here as the mouse exon VII splice variant. We show that the corresponding p42Ets-1 protein is a functional transcription factor with a quite different DNA recognition capacity from that of p51Ets-1. These differences correlate with a distinct regulation of the natural promoter of the VE-cadherin gene. We have identified the p51Ets-1 region which mediates this DNA-sequence specificity of recognition. Overall, our data show that p42Ets-1 is a distinct transcription factor from p51Ets-1.
Results

Identification of the mouse ets-1-dVII variant
The mouse ets-1-dVII transcript was initially observed as a specific minor reverse transcription-polymerase chain reaction (RT-PCR) product when checking endogenous mRNA expression of the full-length Ets-1 (named here p51Ets-1 in correspondence with the human form) in endothelial cells and fibroblasts (E Lelie`vre, unpublished observation). The splicing removes 261 bp from the ets-1 transcript and 87 corresponding amino acids (9.8 kDa) from p51Ets-1, giving rise to a 40.5 kDa protein (named here p42Ets-1). The transcript is expressed in mouse tissues and in endothelial as well as nonendothelial cell lines at consistently lower levels than ets-1 (Figure 1) .
The endogenous mouse p42Ets-1 protein is detectable at much lower amounts than p51Ets-1 in cultured H5V endothelial cells and 3T3 fibroblasts (Figure 2 ), in accordance with the low expression levels of the transcript. As already observed with human Ets-1 isoforms (Koizumi et al., 1990) , mouse Ets-1 proteins migrate as multiple bands, probably corresponding to both isoforms plus their post-translation modified counterparts.
Mouse p42Ets-1 binds DNA Recombinant p42Ets-1 and p51Ets-1 proteins were produced and purified according to the protocol originally designed for p51Ets-1 with minor modifications (Figure 3 ). Recombinant p42Ets-1 binds to DNA and specifically recognizes a classical EBS sequence such as that contained in the MSV-LTR probe (Gunther et al., 1990, Figure 4) . In order to identify the specific DNA sequences that correspond to the optimal-binding sites of p51Ets-1 and p42Ets-1, target detection assays (TDAs) were then performed. The results show that p51Ets-1 and p42Ets-1 have quite significantly different DNA recognition capabilities: p51Ets-1 shows a strong preference for the ACCGGAA/TGTG sequence (Opt), with very limited variations. This Opt sequence is favored by p42Ets-1 too, but other sequences are also frequently pulled out by this variant (Table 1) . The most significant variations are observed at base À1, which is either a C (67%) or an A (33% , Table 1 ), and at base þ 3 (C, 37% or G, 28%). Schematic representation of Ets-1 domains. The exon VII-coded region translates into the region (gray) located immediately ahead of the DNA-binding ETS domain (black). Bottom: The dashed lines illustrate the splicing event. Phosphorylated serine residues (Rabault and Ghysdael, 1994) are indicated by S. a-helices are depicted as boxes, b-strands as arrows. Numbers indicate aminoacid positions. (b) Total RNA (1 mg) from mouse E10.5 embryo (E10.5), 3-day-old pup heart and from various endothelial and fibroblast cell lines were reverse-transcribed and the cDNA (representing 62.5 ng of starting total RNA) amplified using a set of oligonucleotides that flanked exon VII. The amplified products were analysed by agarose gel electrophoresis and ethidium bromide staining. The upper and lower products (arrows) correspond to the ets-1 and ets-1-dVII transcripts, respectively. Numbers indicate product size in bp Figure 2 Detection of Ets-1 isoforms in mouse endothelial and fibroblast cells. H5V endothelial, 3T3 fibroblasts cells or 3T3 cells which had been transfected with pTag-p51Ets-1 or pTagp42Ets-1 were metabolically labelled, cell extracts were prepared and Ets-1 proteins immunoprecipitated using an anti-Ets-1 antibody. The purified material was separated on 10% SDS-PAGE and the gel exposed to autoradiography. p51Ets-1 is detected as a major doublet (*) while p42Ets-1 is present at much lower levels (arrow). ns; nonspecific material Figure 3 Expression and purification of recombinant Ets-1 variants. Recombinant p42Ets-1 and p51Ets-1 were produced in a bacterial expression system and purified . Left: Coomassie blue staining of the purified proteins analysed in 10% SDS-PAGE. Right: Proteins were detected by Western blotting using a specific anti-Ets-1 antibody Identification of the mouse p42Ets-1 isoform F Lionneton et al Base À3 presents some variations as well, T ranking second to A at this position (21 and 54%, respectively).
Electro-mobility shift assays (EMSA) performed using p51Ets-1 or p42Ets-1 and a set of probes that corresponded to the variations suggested by the TDA confirmed that p51Ets-1 and p42Ets-1 bind equally well to Opt (Figure 5 ), whereas changing a single base of this optimal sequence results in mild to severe losses of binding of p51Ets-1: changing base À1 from a C to an A, as in Opt[C À1 A], has a mild effect on the binding of p51Ets-1 while changing this base to G as in Opt[C À1 G] strongly affects p51Ets-1 binding. Neither variation affects p42Ets-1 ( Figure 5 , see also below). The strongest difference is observed when base À1 is changed to a T (Opt[C À1 T]), which induces a total loss of binding of p51Ets-1, although in this case, the binding of p42Ets-1 to DNA is affected too ( Figure 5 ).
Other variations obtained in TDA resulted in less obvious differences in binding capacities when tested by EMSA: when base þ 3 is changed from G to C, as shown with Opt[G þ 3 C], no noticeable difference in binding is observed, although this change is statistically the most common for p42Ets-1 in TDA. Changing the EBS core GGAA to GGAT, which is slightly favored by p42Ets-1 in TDA, has no apparent effect on binding either (Opt[A 0 T], Figure 5 ). These discrepancies illustrate the fact that the frequency at which a sequence is selected by TDA is not exclusively dependent on the relative affinity of the protein for this particular motif. Also, it shows that, although different, some EBS sequences may be recognized with similar apparent affinity by both proteins in EMSA.
Quantification of p51Ets-1 and p42Ets-1 binding to DNA
The characteristics of p51Ets-1 and p42Ets-1 binding to Opt and Opt[C À1 G] and the kinetics of association and release were quantified by surface plasmon resonance (SPR). The Opt[C À1 G] probe was used because p42Ets-1 displayed no apparent differences in binding to Opt[C À1 G] when compared to Opt while a significant loss of binding of p51Ets-1 to Opt[C À1 G] was observed in EMSA.
As expected, the binding characteristics of p51Ets-1 and p42Ets-1 to Opt are quantitatively similar; the association and dissociation curves at low protein concentration are almost equivalent ( Figure 6a ) and the calculated K d within the same range (1.2970.08 vs 0.5670.02 nM for p51Ets-1 and p42Ets-1, respectively, Table 2 ). At the highest concentration used (10 nM, Figure 6b ), after reaching equilibrium, the total amount of p51Ets-1 and p42Ets-1 protein bound to the probe are also equivalent (0.109 vs 0.105 fmol/mm 2 , respectively, at the end of the injection, estimated with the empirical correlation that 1000 RU correspond to 0.1 ng/mm 2 ). On the other hand, striking differences were observed when analysing the binding of the proteins to Opt[C À1 G]: p51Ets-1 shows very weak association to this probe at low concentrations ( Figure 6a ) and the total amounts of protein bound at equilibrium using higher concentrations reaches only 26% of that bound to Opt in similar conditions ( Figure 6b ). As expected from this, the K d value drops to 30.174.5 nM (Table 2 ). These differences are not observed with p42Ets-1, as its rate of association to Opt[C À1 G] is more comparable to that observed with Opt ( Figure 6a ). The only difference is that p42Ets-1 shows a greater dissociation rate, resulting in a 29% decrease of maximal amount of protein bound to Opt[C À1 G] at 10 nM when compared to Opt. Nevertheless, the K d value for p42Ets-1 is still within the range of that obtained with Opt ( Table 2 ).
The Val 280 -Glu 302 region is responsible for the differences in binding to DNA In p42Ets-1, one of the critical regions for the autoinhibited state of Ets-1 is lacking (Jonsen et al., 1996) . In the inhibited status, two exon VII-coded inhibitory helices, named HI1 and HI2 (Figure 1a) , interact with helix H1 of the ETS domain and helix H4 of the carboxy-terminal part of the molecule Skalicky et al., 1996) . We analysed the possible involvement of various parts of this Gly 244 -Thr 330 region, as well as of the C-terminus part of p51Ets-1 in the relative affinity of the protein for the Opt and Opt[C À1 G] DNA sequence. The longer fragment used, DN244, contains the Gly 244 to Thr 440 region (the entire exon VII-coded sequence) plus the ETS domain and the C-terminal part of Ets-1 (Figure 7a) , it encompasses the Val 280 -Asp 440 (DN280) region, which displays binding properties comparable to that of the full-length protein (Petersen et al., 1995; Jonsen et al., 1996; Skalicky et al., 1996) . The other variants Figure 4 EMSA analysis of p42Ets-1 binding to DNA. Binding of p42Ets-1 to the 32 P-labelled double-stranded MSV-LTR DNA probe (arrowhead) is specifically competed for in the presence of a 25-fold molar excess of unlabelled probe (wt) and not by a 100-fold molar excess of mutated probe (mut). p42Ets-1 is supershifted in the presence of anti-Ets-1 antibody (SS), which has no effect on the migration of the probe in the absence of p42Ets-1 (Ab). f; free probe Identification of the mouse p42Ets-1 isoform F Lionneton et al correspond to successive deletions of the exon VII-coded region matching either sides of the HI1 and HI2 domains (Figure 7a ). DN244 displays similar differences in binding to the Opt and Opt[C À1 G] probes than the p51Ets-1 protein (Figure 7) , confirming that the regions responsible for the differences in DNA sequence recognition are located in this part of the p51Ets-1 protein. Similar differences are also observed with DN280. On the other hand, DN303, which starts right at helix HI1, displays much less differences in recognition of the probes, and further deletions completely abolish these differences. Deletion of helix H1 in DN348 prevents binding to either probe, as expected from such a major disruption of the ETS domain. G  3  0  0  0  3 6  3  2 9  A  3 8  2  4  2 0  7  2  8  T  2  3  3  2 6  2  3 7  5  C  3  41  39  0  1  4 
Numbers in boldface correspond to the base position respective to the GGA EBS core. The results of both TDA have been combined. The deduced consensus sequence is shown at the bottom Figure 5 Comparative binding of p51Ets-1 and p42Ets-1 to various DNA sequences. p51Ets-1 and p42Ets-1 (82 pmoles) were mixed with approx 2 ng of 32 P-labelled EBS probes corresponding to Opt (top panel) or various mutations of it as indicated, and analysed by EMSA. Both proteins bound equally well to the Opt probe whereas p42Ets-1 (*) bound much better to the Opt[C À1 G] and to Opt[C À1 T] than p51Ets-1 (arrowhead). À; no Ets-1 protein added Identification of the mouse p42Ets-1 isoform F Lionneton et al Thus, part of the domain mediating the differences in DNA sequence recognition is located within the Val 280 -Gly 302 region. This region is located ahead of helices HI1 and HI2 and is not involved in the autoinhibition mechanism, as the EtsD300 mutant, where most of this region has been deleted, is still autoinhibited (Garvie et al., 2002) . This suggested that autoinhibition was an independent phenomenon from the selection of specific DNA sequences. We therefore tested a variant in which the C-terminal fragment of the protein had been removed while keeping the exon VII-coded region intact (DC415 in Figure 7 ), thus creating a mutation known to release the autoinhibition state of Ets-1 (Lim et al., 1992; Jonsen et al., 1996) . This DC415 variant displays similar differences than p51Ets-1 in binding to the Opt and Opt[C À1 G] DNA probes, confirming that autoinhibition and specific DNA sequence recognition are separate properties of Ets-1.
Transcriptional activities of p51Ets-1 and of p42Ets-1
The promoter of the VE-cadherin gene contains two EBS, named EBS2 and EBS4, which are necessary for the basal transcription of the gene (Gory et al., 1998) , we have shown that p51Ets-1 binds to and activates EBS2 and EBS4, EBS4 being the most important element in response to the factor (Lelie`vre et al., 2000) . Although neither VE-cadherin EBS2 nor EBS4 sequence correspond exactly to the Opt or Opt[C À1 G], EBS2 (AGGG-GAAGTG) closely resembles Opt[C À1 G] while EBS4 (ACAGGAAACC) is closer to Opt[C À1 A], which shows little differences in binding to p51Ets-1 when compared The SPR data set composed of two curves for each concentration (1, 2, 5 and 10 nM) were fitted with Biaeval3.1 s software using the pre-established 1 : 1 binding with mass transfer model. k a , kinetic association constant; k d , kinetic dissociation constant; k t , mass transfer parameter;
, standard statistical measure of the closeness of the fit Identification of the mouse p42Ets-1 isoform F Lionneton et al to p42Ets-1 ( Figure 5 ). The VE-cadherin gene thus provides a natural model for testing and comparing the transcriptional activities of p51Ets-1 and p42Ets-1. First, we compared the binding of p51Ets-1 and p42Ets-1 to the various VE-cadherin EBS and found that both proteins bind similarly to EBS4 while binding of p42Ets-1 to EBS2 is much stronger than that of p51Ets-1 (Figure 8a) . Binding of p42Ets-1 to the other EBS is extremely weak (EBS5) or not detected, as already observed with p51Ets-1 (Figure 8a and Lelie`vre et al., 2000) .
These results prompted us to test the transcriptional activity of the VE-cadherin promoter in response to p51Ets-1 or to p42Ets-1. The natural À2486/ þ 24 fragment of VE-cadherin promoter is activated by p51Ets-1 and p42Ets-1 (thus showing that p42Ets-1 is an active transcription factor, Figure 8b ) while mutation of both EBS abolish the promoter response to p42Ets-1 (À2486EBS2/4M, Figure 8b ), as already observed with p51Ets-1 (Lelie`vre et al., 2000) . Interestingly and in correlation with the EMSA results, inactivation of EBS4 reduces transactivation of the promoter with both factors by half (À2486EBS4M). However, when EBS2 is inactivated, only the transactivation activity of p42Ets-1 is reduced by half whereas transactivation by p51Ets-1 is reduced by only 11.6% (Figure 8b ), confirming that, in cells, p51Ets-1 and p42Ets-1 can differently distinguish and activate EBS present in gene promoters based on their flanking sequence.
Discussion
We have characterized the mouse p42Ets-1 isoform, which corresponds to the splicing variant known in human (Koizumi et al., 1990; Jorcyk et al., 1991) and suspected in rat (Bellacosa et al., 1994) . The description of the specific properties of the human form (Fisher et al., 1994; Rabault and Ghysdael, 1994; Huang et al., 1997; Li et al., 1999; Cowley and Graves, 2000) suggested that, aside from a possible different regulation by protein partners, p42Ets-1 could have different DNA recognition and transcriptional activities compared to p51Ets-1. Our analysis of the DNA-binding sequences of the mouse Ets-1 variants was, first, a validation of the TDA approach as, overall, the optimal ACCGGAA/ TGTG-binding sequence found for p51Ets-1 matched that found by others (Fisher et al., 1991; Nye et al., 1992; Woods et al., 1992) . Regarding the p42Ets-1 protein, aside from the similar Opt-binding site, the main difference in the DNA recognition sequence with p51Ets-1 was found at base À1. Such binding differences are consistent with those observed using the human protein, which shows a lower binding to a GCAG-GAAGTT probe (almost corresponding to Opt[C À1 A] here) than to a GCCGGAAGTT probe (almost corresponding to Opt here) in (Fisher et al., 1991) . Interestingly, the Opt[C À1 G] sequence recognized by p42Ets-1 closely resembles the Spi-1/PU.1 DNA recognition site (Ray-Gallet et al., 1995) , suggesting that p42Ets-1 may regulate Spi-1/PU.1 target genes that would not or barely be affected by p51Ets-1. Extending this idea further, our observations suggest that p51Ets-1 and p42Ets-1 are able to regulate similar target genes through Opt-containing EBS. In such situation and assuming that both proteins have the same half-life, it is expected that the relative amounts of p51Ets-1 and p42Ets-1 would be in favor of a control of the EBS by p51Ets-1. On the other hand, on Opt[C À1 G]-containing natural EBS, the relative amounts of both proteins would not be relevant anymore as p51Ets-1 would not (or barely) bind to these sequences. p42Ets-1 would take control of the EBS no matter how much p51Ets-1 is present. These observations might be of major impor- P-oligonucleotide probes corresponding to the five identified EBS present in the proximal promoter of the VE-cadherin gene and the complexes separated by native PAGE. Binding to EBS4 is comparable for both proteins whereas p42Ets-1 (arrowhead) binds much better to EBS2 than p51Ets-1 (star). Binding to the other EBS is weak or not detected. (b) 3T3 cells were transfected with 2.4 fmoles pcDNA3 control vector (Ctrl, empty bars), pTag-p51Ets-1 (gray bars), or pTagp42Ets-1 (black bars), with 55.2 fmoles of wild-type VEcadherin reporter vector (À2486/ þ 24), or mutated version on EBS2 (À2486EBS2M), on EBS4 (À2486EBS4M), or on both (À2486EBS2/4M), and together with 22.6 fmoles of pCH110 normalization vector. After 2 h, the cells were lysed and the luciferase and b-galactosidase activities measured Identification of the mouse p42Ets-1 isoform F Lionneton et al tance for the regulation of gene promoters which are sensitive to calcium regulation since, as mentioned above, the presence of the exon VII-coded protein sequence confers strong calcium-dependent phosphorylation sensitivity to p51Ets-1 (Rabault and Ghysdael, 1994) and represses DNA binding (Cowley and Graves, 2000) . Since p42Ets-1 is not sensitive to this regulation, it is expected that the Ca 2 þ -regulated expression of Ets-1 target genes will switch between p51Ets-1 and p42Ets-1 depending on the Ca 2 þ status in the cell. This is most probably what happens in the regulation of the GM-CSF promoter/enhancer, which was recently shown to be directly dependent on the phosphorylation state of serine residues located in the exon VII-coded region of Ets-1 (Liu and Grundstrom, 2002) and the tumor necrosis factor-related light gene, which is also Ca 2 þ -sensitive and contains identified Ets-1-binding sites (Castellano et al., 2002) .
It is also probable that the activation of specific genes by p42Ets-1 is due to the interaction of the protein with a different set of transcriptional coregulators than p51Ets-1; p51Ets-1 activity is regulated by cofactors such as CBP/p300 (Yang et al., 1998; Jayaraman et al., 1999), pit-1 (Howard and Maurer, 1995; Bradford et al., 1996 Bradford et al., , 1997 or pax-5 (Fitzsimmons et al., 1996; Garvie et al., 2001) , which interact with different regions of Ets-1. Thus, p51Ets-1 and p42Ets-1 activities could be regulated by common cofactors such as Pit-1, because it interacts with a region different from the exon VIIcoded fragment (Bradford et al., 1995; Bradford et al., 1997) or more specifically by cofactors which interact with the exon VII-coded region, such as by CBFa2 (Goetz et al., 2000) , which would not affect p42Ets-1 function.
The structure of the ETS domain and the role of the exon VII-coded region in the autoinhibitory mechanism of p51Ets-1 have been extensively described Mo et al., 2000; Garvie et al., 2001) . Although these studies precisely addressed the structure of the C-terminal part of the exon VII-coded region, the structure of the region located ahead of HI1 has not been determined yet. It is poorly structured when assessed by NMR (Skalicky et al., 1996) and X-ray crystallography (Garvie et al., 2002) analyses. This is where the Val 280 -Glu 302 region involved in the selection of DNA sequence by p51Ets-1 and p42Ets-1 is located. According to the current knowledge, the involvement of Val 280 -Glu 302 in a direct DNA recognition of base À1 seems improbable but cannot be excluded (Werner et al., 1997; Garvie et al., 2001) . The variability in DNA recognition sequences seen with the p42Ets-1 is more probably due to a major change in protein structure induced by the elimination of the exon VII-coded region. Precise X-ray or NMR structure studies specifically addressing p42Ets-1 bound to the Opt and Opt[C À1 G] DNA sequences should answer this question.
Altogether, our data show that p42Ets-1 acts as a transcription factor distinct from and complementary to p51Ets-1. Ets-1 variants can differentially regulate the VE-cadherin promoter, other reports demonstrated that p42Ets-1 induces specific cellular responses and gene expression (Huang et al., 1997; Li et al., 1999) , however, the role of this variant in vivo remains unclear. The expression of the ets-1 gene has been associated with several aspects of the embryonic development, including vasculogenesis and angiogenesis (Vandenbunder et al., 1989; Pardanaud and Dieterlen-Lie`vre, 1993; Que´va et al., 1993; Maroulakou et al., 1994) , epithelial to mesenchyme transitions (Kola et al., 1993; Que´va et al., 1993) , and implantation (Grevin et al., 1993) . In the adult, ets-1 is expressed in the granulation tissue during wound healing, but also in endothelial cells of solid tumors (Wernert et al., 1992; Vandenbunder et al., 1994) and in the tissue stroma in reaction to tumors Calmels et al., 1995) . ets-1 is also expressed in haematopoietic cells (Kola et al., 1993) , during the lymphoid differentiation (Anderson et al., 1999) , and seems to play an important role in T-cell survival (Bories et al., 1995) and the establishment of NK cells (Barton et al., 1998) . In all these reports, the full-length Ets-1 molecule was commonly considered to be the active form and the role of the ets-1-dVII splice variant has understandably not been addressed. It seems now definitely interesting to specifically assess the contribution of this isoform in these situations and in the several analyses of the role of Ets-1 in the control of gene promoters (Lelie`vre et al., 2001; Oikawa and Yamada, 2003 , for reviews).
Materials and methods
Material
The À2486/ þ 24-Luc, -2486EBS2M, À2486EBS4M, and -2486EBS2/4M reporter vectors were described in Lelie`vre et al. (2000) .
Cells
Mouse heart (H5V) and EOMA endothelioma, brain capillary (MBE) and aortic (MAE) normal endothelial cells, lung endothelial line 1G11, 3T3 and L929 (ATCC) fibroblasts, were cultured following standard conditions in a humidified 5% CO 2 /95% air atmosphere.
Cloning
The ets-1-dVII cDNA was cloned by PCR reaction using reverse transcribed mouse brain capillary endothelial cell total RNA (Lelie`vre et al., 2000) , the TCC GGG CCA TAT GAA GGC GG and GCG CGT CTG TCG ACG ACT AGT CAG oligonucleotides and High Fidelity PCR Master Mix (Roche). The pTag-p51Ets-1 and pTag-p42Ets-1 expression vectors were constructed by cloning the coding sequence of the hemaglutinin influenza epitope ahead of the ets-1 or the ets-1-dVII cDNA into the pcDNA3.1 vector (Invitrogen), respectively.
The DN244, DN280, DN303, D312, D334, and D348 variants were constructed by amplification of the pTag-p51Ets-1 vector using the oligonucleotides TAGGTACCATGGGTAAAC TCGGGGGCCA, TAGGTACCATGGTCCCCTCCTATGA CAG, TAGGTACCATGACCTTCAAGGACTATGT, TAG GTACCATGGCTGACCTCAACAAGGA, TAGGTACCA TGCCGATCCAGCTGTGGCA, TAGGTACCATGAAGT Identification of the mouse p42Ets-1 isoform F Lionneton et al CTTGTCAGTCCTT, respectively, and the reverse primer GCGCGTCTGTCGACGACTAGTCAG. The DC415 construct sequence was amplified using the oligonucleotides TAGGTACCATGGGTAAACTCGGGGGCCA and GATC GTCGACGACTACACAAAGCGGTA. The products were cloned in pcDNA3.1. All constructions were verified by direct sequencing.
RT-PCR analysis
Tissue samples were homogenized in 1 ml TRIzol reagent (Invitrogen) using a Ultrathurax equipped with a 8 mm probe (IKA) and total RNA purified as recommended. Cell cultures were rinsed three times in PBS and lysed in TRIzol reagent.
RT-PCR reactions were performed essentially as in Lelie`vre et al. (2000) .
SDS-PAGE and Western blot analysis
Recombinant Ets-1 proteins were analysed by 10% SDS-PAGE followed either by Coomassie blue staining or by blotting on nitrocellulose (Schleicher and Schuell) and detected using a rabbit polyclonal anti-Ets-1 antibody (1/1000 dilution, C-20, Santa Cruz) revealed using the Renaissance system (NEN).
Metabolic labelling and immunoprecipitation
Cells (10 000/cm 2 ) were plated in 78.5 cm 2 culture plates. Those used for controls were transfected with the pTag-p51Ets-1 or pTag-p42Ets-1 vector as described in 'Transactivation assays' and used the next day. Metabolic labelling was performed by replacing the culture medium with Met/Cys-free DMEM (Invitrogen) and incubating the cells for 30 min prior to the addition of 250 mCi Pro-Mix L-35 S labelling mix (AmershamBiosciences). Cells were labelled for 1 h at which time the monolayers were rinsed with PBS and the cells lysed in 1 ml PBS containing 1% Igepal CA630 (Sigma Chemicals), 0.5% Na deoxycholate, 0.1% SDS (RIPA) and protease inhibitors (Complete, Roche Molecular Biochemicals). Cell extracts (10 7 cpm) were incubated with 1 mg of anti-Ets-1 polyclonal antibody (C-20, Santa Cruz) in 1 ml RIPA overnight on a rotating wheel at 41C. A measure of 50 ml of protein-G sepharose : protein-A sepharose (50 : 50) Fast Flow beads (Amersham-Pharmacia) was added and the incubation carried on for 1 h in similar conditions. Beads were washed four times with 500 ml RIPA, boiled in 2 Â reducing sample buffer and analysed by 10% SDS-PAGE. Gels were fixed, soaked in Amplify reagent (Amersham-Biosciences) and autoradiographed.
Electromobility shift assays
Recombinant Ets-1 proteins (Figures 5 and 8 ) or protein fragments produced in vitro using the TNT coupled reticulocyte lysate system (Figure 7 , Promega) were used. Doublestranded oligonucleotide probes Opt; ACGTACCG-GAAGTGTGCA, or mutated Opt (mutation is indicated in brackets)
Opt 32 P-radio-labelled using T4 polynucleotide kinase. EMSA were performed as described in Lelie`vre et al. (2000) and Lionneton et al. (2001) .
Transactivation assays
3T3 cells (150 000 cells/well) were seeded in 10 cm 2 culture dishes and transfected 16 h later with 2.4 fmol of pTag-p51Ets-1 or pTag-p42Ets-1, 55.2 fmol of reporter vector and 22.6 fmol of pCH110 normalization vector (Amersham-Pharmacia) using Exgen500 (Euromedex). Total amount of DNA were adjusted to 1.5 mg/well with pUC19. After 2 days, cell extracts were prepared in Reporter Lysis buffer (Promega) and luciferase and b-galactosidase activities measured using a Lumat luminometer (Berthold).
Target detection assay
TDA were performed using either the CTCGAGTAGCATG CACANNNNNTCCNNNNNTTGGCCGTCGACTGAGC TC and GCGGAGCTCAGTCGACG (TDA-1) or the CTCG AGTAGCATGCATGNNNNNNNNNNNNNNNCAGGC CGTCGACTGAGCTC (TDA-2) oligonucleotide pairs, essentially as described in Nye et al. (1992) . Binding and amplification steps were repeated two to three times and the final products cloned in the pBlueScriptSKII vector for sequencing. TDA-1 yielded 46 and 57 different clones with p51Ets-1 and p42Ets-1, respectively. The TDA-2 sequence analysis was limited to 18 different clones for each Ets-1 variant.
SPR kinetic assays
Double-stranded biotinylated oligonucleotides (Opt; AGT-CAGTCACGTACCGGAAGTGTGCAGTC, Opt[C À1 G]; AGTCAGTCACGTACGGGAAGTGTGCAGTC), and their respective mutated counterparts serving as controls were immobilized on a streptavidin-coupled CM5 sensor chip (Baillat et al., 2002) . Kinetics experiments were carried out at 101C at a 30 ml/min flow rate in K 3 PO 4 15 mM, pH 7.4, KCl 50 mM, Tween-20 0.005%, 0.1 mg/ml BSA, using a BIAcore 2000 (Biacore s ). Ets-1 isoforms (1, 2, 5 and 10 nM) were injected using the KINJECT procedure during 120 s, dissociation of the complexes was then monitored for 240 s before regeneration with a 60 s injection of 0.03% SDS. Each injection was done twice, raw data were corrected by subtracting the blank curve obtained with the mutated oligonucleotides. Each data set was globally fitted with Biaeval3.1 s software using the pre-established 1 : 1 binding with mass transfer model. The kinetic parameters and the maximum binding capacity of the immobilized ligand were considered as global parameters for a given data set.
Abbreviations EBS, ETS-binding site; EMSA, electro-mobility shift assay; RT, reverse transcription; PCR, polymerase chain reaction; SPR, surface plasmon resonance; TDA, target detection assay.
